Pharma Stock Valuations Are at a Discount, Is Now the Time to Buy?
Pakistan’s pharmaceutical sector has quietly morphed into a compelling value play. Despite major regulatory relief, margin expansion, and earnings growth, valuations across the board remain...
Can Pakistan’s local drugmakers outperform multinationals?
Pakistan’s pharmaceutical sector has entered a phase of structural transformation, and one question stands out: Can local drug manufacturers truly outperform multinational companies (MNCs)? Based...
Pharma sector earnings rise, valuations fall: is it a buying opportunity?
The pharmaceutical sector in Pakistan delivered a strong performance in 1QCY25, with listed companies showing robust profitability driven by favorable macro and regulatory developments. Using...
GlaxoSmithKline (GLAXO) is ready for a bullish rally
Glaxo Smith Kline is currently consolidating after a long bullish rally. Key resistance lies at 445-446. A break above this level will lead to further...
GLAXO EPS Forecast
According to our database, the following research houses have published their GLAXO EPS ForecastGLAXO Target Price
According to our database, GLAXO has an average analyst price target for Dec 2025 of Rs. 410 based on estimates of 1 analyst. This includes...